Author

Christopher Chester

Cancer Research UK Manchester Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Andrew D. CampbelliD· 1 shared Catriona A. FordiD· 1 shared Gareth J. InmaniD· 1 shared Georgios KanellosiD· 1 shared Owen James SansomiD· 1 shared Patricia P. CentenoiD· 1 shared Patrizia CammareriiD· 1 shared Rachel A. RidgwayiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Andrew D. CampbellORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

SOX2 empowers a rapid tumorigenic programme from the tumour resistant population in the skin

Patricia P. Centeno, Christopher Chester, Georgios Kanellos, Catriona A. Ford, Patrizia Cammareri, Gareth J. Inman, Thomas J. Jamieson, Rachel A. Ridgway, Richard Marais, Andrew D. Campbell, Owen James Sansom

This study identifies SOX2 as a key driver of rapid tumorigenesis from a previously resistant skin cell population in mice, with implications for human cutaneous squamous cell carcinoma.

Nature Communications · Jan 8, 2026Peer-reviewedCancer Biology